Rayvolve PTX-PE
K243808AZmed · cleared 2025-03-21 · product code QFM · Radiology
Premarket evidence — what FDA accepted
source quote (p.8)
“Rayvolve PTX-PE is a software-only device designed to help healthcare professionals. It's a radiological computer-assisted triage and notification software that analyzes chest x-ray images (Postero-Anterior (PA) or Antero-Posterior (AP)) of patients of 18 years of age or older for the presence of pre-specified suspected critical findings (pleural effusion and/or pneumothorax).”
source quote (p.4)
“Rayvolve PTX-PE uses an artificial intelligence algorithm to analyze the images for features suggestive of critical findings and provides study-level output available in DICOM node servers for worklist prioritization or triage.”
Validation studies (1)
Standalone
n=2,000 images
endpoints: Detects pneumothorax with high sensitivity; Detects pleural effusion with high sensitivity; performance time
Reported performance (3 observations)
source quote (p.16)
“Detects pneumothorax with high sensitivity (0.9379, 95% Confidence interval (CI): 0.9127; 0.9561)”
source quote (p.16)
“high specificity (0.9448, 95% Confidence Interval (CI): 0.9239; 0.9339)”
source quote (p.16)
“high area under the Curve (AUC) of the Receiver Operating Characteristic (ROC) (0.9857, 95% Confidence Interval (CI): 0.9809; 0.9901)”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
- re_clearance
The FDA AI/ML device list shows a newer 510(k) K243831 (decision 2025-03-26) from AZmed for a matching device line ("Rayvolve LN") — a new clearance for the same line is a change event.
first seen 2026-07-08 · k_number:K243831
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).